Skip to main content

Closed

ANRO: Alto Neuroscience, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Operating margin0.0%

ROIC20.7%

Financially safe

Strong

Debt / equity0.02×

Interest coverage22.7×

Current ratio20.52×

Alto Neuroscience, Inc.

ANRONew York Stock Exchange·USD·Closed

Alto Neuroscience, Inc.

ANRONew York Stock Exchange·USD·Closed

$27.07

−5.45%

$27.07

−$1.56 (5.45%)

52W Range

93thpctl

Volume

0.48×avg

Mkt Cap

949.99MUSD

P/E

-10.9TTM

Div Yield

–ann

52W Range

93thpctl

Volume

0.48×avg

Market Cap

949.99MUSD

P/E Ratio

-10.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings